Alcoholic liver injury: Pathogenesis and therapy in 2001

Pathologie Biologie

Volumn 49, Issue 9, 2001, Pages 738-752

  Lieber, C S ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Alcoholic liver disease; CYP2E1; Diagnosis; Dilinoleoylphosphatidylcholine (DLPC); Polyenylphosphatidylcholine (PPC); S adenosylmethionine (SAMe); Therapy

Indexed keywords

ACAMPROSATE; ALCOHOL; ALCOHOL DEHYDROGENASE; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; BETA CAROTENE; CAROTENOID; COLCHICINE; CYTOCHROME P450 2E1; FREE RADICAL; INTERFERON; MEDIUM CHAIN TRIACYLGLYCEROL; METHIONINE; NALTREXONE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE METHYLTRANSFERASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; RETINOID DERIVATIVE; S ADENOSYLMETHIONINE;

ALCOHOL LIVER DISEASE; ARTICLE; DIET THERAPY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME INHIBITION; FATTY LIVER; HEPATITIS C; HUMAN; LIVER FIBROSIS; LIVER TRANSPLANTATION; NONHUMAN; NUTRITIONAL DEFICIENCY; OXIDATIVE STRESS; PATHOGENESIS; TREATMENT PLANNING;

EID: 0035178103     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0369-8114(01)00239-5     Document Type: Article

References (97)

1. Effects of prolonged ethanol intake: Production of fatty liver despite adequate diets
2. Ultrastructural alterations in human hepatocytes following ingestion of ethanol with adequate diets
3. Perivenular fibrosis as precursor lesion of cirrhosis
4. Attenuation of alcohol-induced hepatic fibrosis by polyunsaturated lecithin
5. Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon
6. Portal Fibrohlasts and myofibroblasts in baboons after long-term alcohol consumption
7. Lipocytes and transitional cells in alcoholic liver disease: A morphometric study
8. Alcoholic liver injury in baboons: Transformation of lipocytes to transitional cells
9. Acetaldehyde selectively stimulates collagen production in cultured rat liver-storing cells but not in hepatocytes
10. The evolution of human cirrhosis deduced from observations in experimental animals
11. Occlusive venous lesions in alcoholic liver disease. A study of 200 cases
12. Early perivenular sclerosis in alcoholic fatty liver: An index of progressive liver injury
13. Alterations in endothelial fenestrations in liver sinusoids of baboons fed alcohol: A scanning electron microscopic study
14. Alcohol related diseases and carcinogenesis
15. Naltrexone and coping skills therapy for alcohol dependence
16. Combined efficacy of acamprosate and disulfiram in the treatment of alcoholism: A controlled study
17. Prognostic factors in alcoholic liver disease
18. An experimental model of alcohol feeding and liver injury in the baboon
19. 6 metabolism in chronic alcohol abuse
20. S-adenosyl-L-methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis
21. Regulation by hypoxia of methionine adenosyltransferase activity and gene expression in rat hepatocytes
22. S-adenosyl-L-methionine attenuates alcohol-induced liver injury in the baboon
23. Chronic ethanol consumption alters rat liver plasma membranes and potentiates release of alkaline phosphatase
24. Intestinal absorption of S-adenosyl-L-methionine
25. Intestinal absorption of S-adenosyl-L-methionine in humans
26. The use of ademethionine (SAMe) in the treatment of cholestatic liver disorders: Meta-analysis of clinical trials
27. Reversal of intrahepatic cholestasis of pregnancy in women after high dose S-adenosyl-L-methionine administration
28. Oral S-adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis: A double-blind placebo controlled study
29. Effect of oral S-adenosyl-L-methionine on hepatic glutathione in patients with liver disease
30. S-Adenosylmethionine in alcoholic liver cirrhosis: A randomized, placebo-controlled, double-blind, multicentre clinical trial
31. Hepatic phosphatidylethanolamine methyltransferase activity is decreased by ethanol and increased by phosphatidylcholine
32. Choline fails to prevent liver fibrosis in ethanol-fed baboons hut causes toxicity
33. Dietary linoleic acid is required for development of experimentally induced alcoholic liver injury
34. Increased type I procollagen mRNA levels and in vitro protein synthesis in the baboon model of chronic alcoholic liver disease
35. Dilinoleoylphosphatidylcholine decreases hepatic stellate cell activation
36. Biochemical and morphological alterations of baboon hepatic mitochondria after chronic ethanol consumption
37. 3 content and changes in phospholipids
38. Polyenylphosphatidylcholine attenuates alcohol-induced fatty liver and hyperlipemia in rats
39. Ethanol and signal transduction in the liver
40. Polyenylphosphatidylcholine decreases alcohol-induced oxidative stress in the baboon
41. Polyenylphosphatidylcholine attenuates non-alcoholic hepatic fibrosis and accelerates its regression
42. Polyunsaturated lecithin prevents acetaldehyde-mediated hepatic collagen accumulation by stimulating collagenase activity in cultured stellate cells
43. Polyunsaturated phosphatidyl-choline and interferon alpha for treatment of chronic hepatitis B and C: A multicenter, randomized, double blind, placebo-controlled trial
44. Alcohol, vitamin A, and beta-carotene: Adverse interactions, including hepatotoxicity and carcinogenicity
45. Hepatic vitamin A depletion in alcoholic liver injury
46. Hepatic vitamin A depletion after chronic ethanol consumption in baboons and rats
47. Changes in vitamin A status after acute ethanol administration in the rat
48. Increased metabolism of retinoic acid after chronic ethanol consumption in rat liver microsomes
49. Decreased hepatic vitamin A after drug administration in men and in rats
50. Potentiation of ethanol-induced hepatic vitamin A depletion by phenobarbital and butylated hydroxytoluene
51. Retinoic acid metabolism by a system reconstituted with cytochrome P-450
52. New pathway for retinol metabolism in liver microsomes
53. NAD+-dependent retinol dehydrogenase in liver microsomes
54. Metabolism of retinol and retinoic acid by human liver cytochrome P450IIC8
55. Effect of hepatic vitamin A depletion on the liver in humans and rats
56. Exacerbation by ethanol of liver injury due to vitamin A deficiency and excess
57. Potentiation by ethanol consumption of tracheal squamous metaplasia caused by vitamin A deficiency in rats
58. Interaction of drugs and retinol
59. Chronic alcohol intake reduces retinoic acid concentration and enhances AP-1 (c-Jun and c-Fos) expression in rat liver
60. Liver damage caused by therapeutic vitamin A administration: Estimate of dose related toxicity in 41 cases
61. Hepatotoxicity of vitamin A and ethanol in the rat
62. Treatment with vitamin A of sexual dysfunction in male alcoholics
63. Hepatic fibrosis after long term administration of ethanol and moderate vitamin A supplementation in the rat
64. Interactions between alcohol and beta-carotene in patients with alcoholic liver disease
65. Interaction of ethanol with β-carotene: Delayed blood clearance and enhanced hepatotoxicity
66. B-carotene beadlets potentiate hepatotoxicity of alcohol
67. Oxidative changes associated with B-carotene and α-tocopherol enrichment of human low-density lipoproteins
68. The effect of vitamin E and β-carotene on the incidence of lung cancer and other cancers in male smokers
69. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
70. Role of intestinal bacterial overgrowth in ethanol production and metabolism in rats
71. The effect of ethanol on fatty acid metabolism: Stimulation of hepatic fatty acid synthesis in vitro
72. Effects of butylated hydroxytoluene on the ultrastructure of rat hepatocytes
73. Hepatic microsomal ethanol oxidizing system: In vitro characteristics and adaptive properties in vivo
74. Reconstitution of the microsomal ethanoloxidizing system: Qualitative and quantitative changes of cytochrome P-450 after chronic ethanol consumption
75. Purification and characterization of a unique isozyme of cytochrome P-450 from liver microsomes of ethanol-treated rabbits
76. Purification and characterization of human liver cytochrome P-450-ALC
77. The intralobular distribution of ethanol-inducible P450IIE1 in rat and human liver
78. Respective roles of human cytochrome P4502E1, 1A2, and 3A4 in the hepatic microsomal ethanol oxidizing system
79. Non-uniformity of blood ethanol elimination: Its exaggeration after chronic consumption
80. Increase of ethanol meprobamate and pentobarbital metabolism after chronic ethanol administration in man and in rats
81. Induction of P450IIE1 in the obese rat
82. Hepatic cytochrome P4502E1 is increased in patients with nonalcoholic steatohepatitis
83. Differential depletion of carotenoids and tocopherol in liver diseases
84. Acetaldehyde increases procollagen type I and fibronectin gene transcription in cultured rat fat-storing cells through a protein synthesis-dependent mechanism
85. Reduced nicotinamide-adenine dinucleotide phosphate oxidase: Activity enhanced by ethanol consumption
86. Induction of cytochrome P-4502E1 by ethanol in rat Kupffer cells
87. Depressed hepatic glutathione and increased diene conjugates in alcoholic liver disease: Evidence of lipid peroxidation
88. Hepatic mitochondrial glutathione depletion and progression of experimental alcoholic liver disease in rats
89. Polyenylphosphatidylcholine opposes the increase of cytochrome P4502E1 by ethanol and corrects its iron-induced decrease
90. Hepatic, metabolic and nutritional disorders of alcoholism: From pathogenesis to therapy
91. Difference in hepatic metabolism of long and medium-chain fatty acids: The role of fatty acid chain length in the production of the alcoholic fatty liver
92. A randomized trial of prednisolone in patients with severe alcoholic hepatitis
93. Dilinoleoylphosphatidylcholine selectively modulates lipopolysaccharide-induced Kupffer cell activation
94. Collagen synthesis by liver stellate cells is released from its normal feedback regulation by acetaldehyde-induced modification of the carboxyl-terminal propeptide of procollagen
95. Oxidative stress, antioxidants, and alcoholic liver fibrogenesis
96. Alcoholism is associated with hepatitis C but not hepatitis B in an urban population